Clinical Trial Results TV
September 26, 2019: Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss: First Human Use of a Novel Subcutaneous Platelet GPIIb/IIIa Inhibi
Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss: First Human Use of a Novel
Subcutaneous Platelet GPIIb/IIIa Inhibitor (RUC-4) Designed for STEMI Point of Care
Treatment

TBD

[ Download video ]


Video Statistics
0 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 0 total votes.

These statistics are updated nightly. The last update ran on
10-19-2019 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted